Natalie O’Donnell, Head of Safety & Risk Management, Presents a REMS Overview.
November 20, 20256 min read
Datavant and UBC Partner to Transform Observational Research and Patient Access for Biopharmaceutical Sponsors
Datavant and United BioSource Corporation (UBC) have joined forces to transform late-phase research and patient access programs for biopharmaceutical sponsors. By combining Datavant’s privacy-first data connectivity with UBC’s expertise in specialty therapies, the partnership introduces two new offerings: Modern Observational Research Study Designs and Enhanced Patient Access Programs. These solutions aim to accelerate evidence generation, improve patient outcomes, and set a new standard for real-world research and access.

